deltatrials
Completed OBSERVATIONAL NCT01496014

Assessment of Severe Extremity Wound Bioburden at the Time of Definitive Wound Closure or Coverage (Bioburden)

Assessment of Severe Extremity Wound Bioburden at the Time of Definitive Wound Closure or Coverage: Correlation With Subsequent Post-Closure Deep Wound Infection: Bioburden Study

Sponsor: Major Extremity Trauma Research Consortium

Conditions Open Fracture
Updated 19 times since 2017 Last updated: Jul 27, 2022 Started: Sep 30, 2011 Primary completion: Sep 30, 2016 Completion: Jun 30, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Open Fracture, this trial is completed. The trial is conducted by Major Extremity Trauma Research Consortium and has accumulated 19 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Dec 2018 · 3 months · monthly snapshot~Dec 2018 – ~Aug 2019 · 8 months · monthly snapshot~Aug 2019 – ~Nov 2019 · 3 months · monthly snapshot~Nov 2019 – ~Aug 2020 · 9 months · monthly snapshot~Aug 2020 – ~Nov 2020 · 3 months · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Dec 2021 · 6 months · monthly snapshot~Dec 2021 – ~Sep 2022 · 9 months · monthly snapshot~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

19 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Sep 2022 — Jul 2024 [monthly]

    Completed

    Status: Active Not RecruitingCompleted

  5. Dec 2021 — Sep 2022 [monthly]

    Active Not Recruiting

Show 14 earlier versions
  1. Jun 2021 — Dec 2021 [monthly]

    Active Not Recruiting

  2. Jan 2021 — Jun 2021 [monthly]

    Active Not Recruiting

  3. Dec 2020 — Jan 2021 [monthly]

    Active Not Recruiting

  4. Nov 2020 — Dec 2020 [monthly]

    Active Not Recruiting

  5. Aug 2020 — Nov 2020 [monthly]

    Active Not Recruiting

  6. Nov 2019 — Aug 2020 [monthly]

    Active Not Recruiting

  7. Aug 2019 — Nov 2019 [monthly]

    Active Not Recruiting

  8. Dec 2018 — Aug 2019 [monthly]

    Active Not Recruiting

  9. Sep 2018 — Dec 2018 [monthly]

    Active Not Recruiting

    Status: Unknown StatusActive Not Recruiting

  10. Jun 2018 — Sep 2018 [monthly]

    Unknown Status

  11. May 2018 — Jun 2018 [monthly]

    Unknown Status

    Status: Active Not RecruitingUnknown Status

  12. Apr 2018 — May 2018 [monthly]

    Active Not Recruiting

    Phase: NANone

  13. Aug 2017 — Apr 2018 [monthly]

    Active Not Recruiting NA

  14. Jan 2017 — Aug 2017 [monthly]

    Active Not Recruiting NA

    First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Major Extremity Trauma Research Consortium
  • United States Department of Defense
Data source: Major Extremity Trauma Research Consortium

For direct contact, visit the study record on ClinicalTrials.gov .